Derma Sciences (DSCI) Tops Q1 EPS by 6c; Outlook Affirmed
Tweet
Share
E-mailGet Alerts DSCI Hot Sheet
Price: $7.00 --0%
Financial Fact:
Loss before income taxes: -6.03M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Loss before income taxes: -6.03M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Derma Sciences (NASDAQ: DSCI) reported Q1 EPS of ($0.07), $0.06 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $20.2 million versus the consensus estimate of $20.6 million.
Derma Sciences reaffirmed FY2016 guidance.
For earnings history and earnings-related data on Derma Sciences (DSCI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
- Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
